Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Oxenkrug

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Molecular Neurobiology|July 2, 2013
Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathwaysGregory Oxenkrug
Annals of the New York Academy of Sciences|September 24, 2005
Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implicationsGregory Oxenkrug
Aging and Disease|March 8, 2012
Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric DisordersGregory Oxenkrug
International Journal of Molecular Sciences|January 8, 2025
Anthranilic Acid-G-Protein Coupled Receptor109A-Cytosolic Phospholipase A2-Myelin-Cognition Cascade: A New Target for the Treatment/Prevention of Cognitive Impairment in Schizophrenia, Dementia, and AgingGregory Oxenkrug
Current Drug Targets|March 22, 2013
Serotonin-kynurenine hypothesis of depression: historical overview and recent developmentsGregory Oxenkrug
The Journal of Clinical Psychiatry|July 7, 2017
Low Nitric Oxide and High C-Reactive Protein in Depression: Not a Paradox!Gregory Oxenkrug
Molecular Neurobiology|September 14, 2019
Benserazide, an Inhibitor of Peripheral Kynurenine Metabolism, Attenuates Olanzapine-Induced Weight Gain, Insulin Resistance, and Dyslipidemia in C57Bl/6j MiceGregory Oxenkrug, Paul Summergrad
Aging and Disease|November 28, 2012
N-acetylserotonin and aging-associated cognitive impairment and depressionGregory Oxenkrug, Rebbie Ratner
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2014
Merton SandlerGregory Oxenkrug, David Healy
International Journal of Tryptophan Research : IJTR|March 27, 2024
Anthranilic Acid, a GPR109A Agonist, and SchizophreniaGregory Oxenkrug, Brent Forester
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Molecular Neurobiology|July 2, 2013
Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathwaysGregory Oxenkrug
Annals of the New York Academy of Sciences|September 24, 2005
Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implicationsGregory Oxenkrug
Aging and Disease|March 8, 2012
Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric DisordersGregory Oxenkrug
International Journal of Molecular Sciences|January 8, 2025
Anthranilic Acid-G-Protein Coupled Receptor109A-Cytosolic Phospholipase A2-Myelin-Cognition Cascade: A New Target for the Treatment/Prevention of Cognitive Impairment in Schizophrenia, Dementia, and AgingGregory Oxenkrug
Current Drug Targets|March 22, 2013
Serotonin-kynurenine hypothesis of depression: historical overview and recent developmentsGregory Oxenkrug
The Journal of Clinical Psychiatry|July 7, 2017
Low Nitric Oxide and High C-Reactive Protein in Depression: Not a Paradox!Gregory Oxenkrug
Molecular Neurobiology|September 14, 2019
Benserazide, an Inhibitor of Peripheral Kynurenine Metabolism, Attenuates Olanzapine-Induced Weight Gain, Insulin Resistance, and Dyslipidemia in C57Bl/6j MiceGregory Oxenkrug, Paul Summergrad
Aging and Disease|November 28, 2012
N-acetylserotonin and aging-associated cognitive impairment and depressionGregory Oxenkrug, Rebbie Ratner
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2014
Merton SandlerGregory Oxenkrug, David Healy
International Journal of Tryptophan Research : IJTR|March 27, 2024
Anthranilic Acid, a GPR109A Agonist, and SchizophreniaGregory Oxenkrug, Brent Forester
Pageof 3